Experts at Cincinnati Children's report proof-of-concept results that may sharply reduce the risk of a lethal side effect that has negatively impacted the use of revolutionary cancer immunotherapies ...

The open-label, single-arm study enrolled 23 adult patients undergoing their first kidney transplant from either living or ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...

A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...

Integrative genomic landscape of germline exome alterations in renal cell carcinoma, unclassified with medullary phenotype. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers ...

New study reveals ALK mutation enhances tumor immunogenicity and predicts favorable outcomes in immune checkpoint blockade ...